Nanotechnology-driven optogenetics for therapeutic grade interventions.
Abstract:
Optogenetics, a biotechnology that combines optical and genetic strategies to regulate cellular and tissue functions with high spatial and temporal precision, serves as a powerful tool-level regulatory technology widely employed to investigate cellular processes and elucidate disease mechanisms. Nanotechnology-driven optogenetics, which incorporates nanomaterials/nanostructures to improve the efficacy and broaden the applications of optogenetic systems, synergistically integrates the precision, tunability, and multifunctionality of nanotechnology with the spatiotemporal control inherent to optogenetics. The development not only enhances the flexibility and efficiency of optogenetic technology but also advances the field toward therapeutic-grade interventions. In this review, we summarize recent advances in nanotechnology-driven optogenetics, with a particular emphasis on three key areas: (1) nanostructured light sources for the precise activation of optogenetic systems, which include both externally light-stimulated systems and systems that operate independently of external light sources; (2) nanotechnology-enabled targeted delivery of light-sensitive proteins and genetic constructs to ensure efficient modulation of optogenetic pathways, which specifically involves the nanotechnology-assisted gene, protein, and recombinase enzyme delivery approaches; and (3) nanotechnology-driven therapeutic applications of optogenetics, including CAR T cell immunotherapy, cancer treatment, neurological interventions, and cardiac therapies. We further discuss the current challenges facing this emerging field and outline future research directions. This review aims not only to highlight recent breakthroughs but also to position nanotechnology-driven optogenetics as a promising tool for next-generation precision medicine.
